Literature DB >> 26037681

Cyclodextrin nanoassemblies: a promising tool for drug delivery.

Véronique Bonnet1, Cédric Gervaise2, Florence Djedaïni-Pilard3, Aurélien Furlan4, Catherine Sarazin4.   

Abstract

Among the biodegradable and nontoxic compounds that can form nanoparticles for drug delivery, amphiphilic cyclodextrins are very promising. Apart from ionic cyclodextrins, which have been extensively studied and reviewed because of their application in gene delivery, our purpose is to provide a clear description of the supramolecular assemblies of nonionic amphiphilic cyclodextrins, which can form nanoassemblies for controlled drug release. Moreover, we focus on the relationship between their structure and physicochemical characteristics, which is crucial for self assembly and drug delivery. We also highlight the importance of the nanoparticle technology preparation for the stability and application of this nanodevice.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26037681     DOI: 10.1016/j.drudis.2015.05.008

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  16 in total

1.  Supramolecular Complex of Ibuprofen with Larch Polysaccharide Arabinogalactan: Studies on Bioavailability and Pharmacokinetics.

Authors:  Mikhail V Khvostov; Sergey A Borisov; Tatjana G Tolstikova; Alexander V Dushkin; Biligma D Tsyrenova; Yulia S Chistyachenko; Nikolay E Polyakov; Galina G Dultseva; Andrey A Onischuk; Sergey V An'kov
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

2.  Cyclodextrin polymers decorated with RGD peptide as delivery systems for targeted anti-cancer chemotherapy.

Authors:  Maurizio Viale; Rita Tosto; Valentina Giglio; Giuseppe Pappalardo; Valentina Oliveri; Irena Maric; Maria Addolorata Mariggiò; Graziella Vecchio
Journal:  Invest New Drugs       Date:  2018-12-17       Impact factor: 3.850

3.  Why does β-cyclodextrin prefer to bind nucleotides with an adenine base rather than other 2'-deoxyribonucleoside 5'-monophosphates?

Authors:  Dongsheng Zhang; Jingjing Liu; Teng Wang; Liping Sun
Journal:  J Mol Model       Date:  2017-04-01       Impact factor: 1.810

Review 4.  Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances.

Authors:  Khaled Mahmoud; Shady Swidan; Mohamed El-Nabarawi; Mahmoud Teaima
Journal:  J Nanobiotechnology       Date:  2022-03-05       Impact factor: 10.435

Review 5.  Polysaccharide-Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to Bedside.

Authors:  Tianxin Miao; Junqing Wang; Yun Zeng; Gang Liu; Xiaoyuan Chen
Journal:  Adv Sci (Weinh)       Date:  2018-01-08       Impact factor: 16.806

Review 6.  Use of Cyclodextrins in Anticancer Photodynamic Therapy Treatment.

Authors:  Amina Ben Mihoub; Ludivine Larue; Albert Moussaron; Zahraa Youssef; Ludovic Colombeau; Francis Baros; Céline Frochot; Régis Vanderesse; Samir Acherar
Journal:  Molecules       Date:  2018-08-02       Impact factor: 4.411

7.  Cyclodextrin-Modified CeO2 Nanoparticles as a Multifunctional Nanozyme for Combinational Therapy of Psoriasis.

Authors:  Lingyun Wu; Guoyan Liu; Wenyu Wang; Ruobing Liu; Lingyan Liao; Ni Cheng; Wentong Li; Weifen Zhang; Dejun Ding
Journal:  Int J Nanomedicine       Date:  2020-04-15

8.  β-Cyclodextrin-poly (β-Amino Ester) Nanoparticles Are a Generalizable Strategy for High Loading and Sustained Release of HDAC Inhibitors.

Authors:  Sauradip Chaudhuri; Martha J Fowler; Cassandra Baker; Sylwia A Stopka; Michael S Regan; Lindsey Sablatura; Colton W Broughton; Brandon E Knight; Sarah E Stabenfeldt; Nathalie Y R Agar; Rachael W Sirianni
Journal:  ACS Appl Mater Interfaces       Date:  2021-04-27       Impact factor: 9.229

Review 9.  The Smart Drug Delivery System and Its Clinical Potential.

Authors:  Dong Liu; Fang Yang; Fei Xiong; Ning Gu
Journal:  Theranostics       Date:  2016-06-07       Impact factor: 11.556

10.  Linear Cyclodextrin Polymer Prodrugs as Novel Therapeutics for Niemann-Pick Type C1 Disorder.

Authors:  Aditya Kulkarni; Paola Caporali; Atul Dolas; Soniya Johny; Sandeep Goyal; Jessica Dragotto; Alberto Macone; Ramesh Jayaraman; Maria Teresa Fiorenza
Journal:  Sci Rep       Date:  2018-06-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.